2pni › Citations

Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase.

Booker GW, Gout I, Downing AK, Driscoll PC, Boyd J, Waterfield MD, Campbell ID
Cell 73 813-22 (1993)
Cited: 120 times
EuropePMC logo PMID: 7684655

Abstract

SH3 domains are found in proteins associated with receptor tyrosine kinase signal transduction complexes. The solution structure of the SH3 domain of the 85 kd regulatory subunit of phosphatidylinositol 3-kinase is shown to be a compact beta barrel consisting of five beta strands arranged in two beta sheets of three and two strands. The structure is similar to that of chicken brain alpha spectrin but represents a distinct class of SH3 domain, with an insertion between the second and third beta strands that may influence binding specificity. 1H chemical shift changes induced by complex formation with a synthetic peptide derived from the SH3-binding protein dynamin, together with amino acid sequence comparisons, suggest that the ligand-binding site consists of a hydrophobic surface flanked by two charged loops.

Reviews - 2pni mentioned but not cited (3)

  1. What lessons can be learned from studying the folding of homologous proteins? Nickson AA, Clarke J. Methods 52 38-50 (2010)
  2. Somatic mutations in PI3Kalpha: structural basis for enzyme activation and drug design. Gabelli SB, Mandelker D, Schmidt-Kittler O, Vogelstein B, Amzel LM. Biochim Biophys Acta 1804 533-540 (2010)
  3. Overview of protein structural and functional folds. Sun PD, Foster CE, Boyington JC. Curr Protoc Protein Sci Chapter 17 Unit 17.1 (2004)

Articles - 2pni mentioned but not cited (2)

  1. Critical nucleation size in the folding of small apparently two-state proteins. Bai Y, Zhou H, Zhou Y. Protein Sci 13 1173-1181 (2004)
  2. Fold and flexibility: what can proteins' mechanical properties tell us about their folding nucleus? Sacquin-Mora S. J R Soc Interface 12 20150876 (2015)


Reviews citing this publication (23)

  1. Phosphoinositide kinases. Fruman DA, Meyers RE, Cantley LC. Annu Rev Biochem 67 481-507 (1998)
  2. The structure and function of proline-rich regions in proteins. Williamson MP. Biochem J 297 ( Pt 2) 249-260 (1994)
  3. Structure and function of phosphoinositide 3-kinases. Wymann MP, Pirola L. Biochim Biophys Acta 1436 127-150 (1998)
  4. The PH domain: a common piece in the structural patchwork of signalling proteins. Musacchio A, Gibson T, Rice P, Thompson J, Saraste M. Trends Biochem Sci 18 343-348 (1993)
  5. ZO-1, DlgA and PSD-95/SAP90: homologous proteins in tight, septate and synaptic cell junctions. Woods DF, Bryant PJ. Mech Dev 44 85-89 (1993)
  6. SH3 domains and drug design: ligands, structure, and biological function. Dalgarno DC, Botfield MC, Rickles RJ. Biopolymers 43 383-400 (1997)
  7. Structure and function of the SH3 domain. Musacchio A, Wilmanns M, Saraste M. Prog Biophys Mol Biol 61 283-297 (1994)
  8. Structure, regulation and function of phosphoinositide 3-kinases. Fry MJ. Biochim Biophys Acta 1226 237-268 (1994)
  9. Amyloidogenesis of natively unfolded proteins. Uversky VN. Curr Alzheimer Res 5 260-287 (2008)
  10. Tec family of protein-tyrosine kinases: an overview of their structure and function. Mano H. Cytokine Growth Factor Rev 10 267-280 (1999)
  11. Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Djordjevic S, Driscoll PC. Trends Biochem Sci 27 426-432 (2002)
  12. Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. Blackwell JM, Barton CH, White JK, Roach TI, Shaw MA, Whitehead SH, Mock BA, Searle S, Williams H, Baker AM. Immunol Lett 43 99-107 (1994)
  13. SH3 domains. Molecular 'Velcro'. Morton CJ, Campbell ID. Curr Biol 4 615-617 (1994)
  14. Role of PI 3-kinase in mitogenesis. Varticovski L, Harrison-Findik D, Keeler ML, Susa M. Biochim Biophys Acta 1226 1-11 (1994)
  15. Dynamin, endocytosis and intracellular signalling (review). McClure SJ, Robinson PJ. Mol Membr Biol 13 189-215 (1996)
  16. SH2 and SH3 domains as targets for anti-proliferative agents. Vidal M, Gigoux V, Garbay C. Crit Rev Oncol Hematol 40 175-186 (2001)
  17. Rasputin a decade on and more promiscuous than ever? A review of G3BPs. Alam U, Kennedy D. Biochim Biophys Acta Mol Cell Res 1866 360-370 (2019)
  18. The GRB family of SH2 domain proteins. Margolis B. Prog Biophys Mol Biol 62 223-244 (1994)
  19. New insights into protein-tyrosine kinase receptor signaling complexes. Fry MJ, Panayotou G, Booker GW, Waterfield MD. Protein Sci 2 1785-1797 (1993)
  20. Src inhibitors: genomics to therapeutics. Sawyer T, Boyce B, Dalgarno D, Iuliucci J. Expert Opin Investig Drugs 10 1327-1344 (2001)
  21. The multi-functional RNA-binding protein G3BP1 and its potential implication in neurodegenerative disease. Sidibé H, Dubinski A, Vande Velde C. J Neurochem 157 944-962 (2021)
  22. Involvement of crk adapter proteins in regulation of lymphoid cell functions. Gelkop S, Babichev Y, Kalifa R, Tamir A, Isakov N. Immunol Res 28 79-91 (2003)
  23. Role(s) of G3BPs in Human Pathogenesis. Mukhopadhyay C, Zhou P. J Pharmacol Exp Ther 387 100-110 (2023)

Articles citing this publication (92)

  1. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Nature 416 507-511 (2002)
  2. Amyloid fibril formation by an SH3 domain. Guijarro JI, Sunde M, Jones JA, Campbell ID, Dobson CM. Proc Natl Acad Sci U S A 95 4224-4228 (1998)
  3. SH2 and SH3 domains. Pawson T, Schlessingert J. Curr Biol 3 434-442 (1993)
  4. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H. EMBO J 13 3748-3756 (1994)
  5. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW. Cell 75 25-36 (1993)
  6. Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110alpha catalytic subunit by the p85 regulatory subunit. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM. Mol Cell Biol 18 1379-1387 (1998)
  7. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. Jiménez JL, Guijarro JI, Orlova E, Zurdo J, Dobson CM, Sunde M, Saibil HR. EMBO J 18 815-821 (1999)
  8. Diaphanous-related formins bridge Rho GTPase and Src tyrosine kinase signaling. Tominaga T, Sahai E, Chardin P, McCormick F, Courtneidge SA, Alberts AS. Mol Cell 5 13-25 (2000)
  9. Cloning and characterization of hdlg: the human homologue of the Drosophila discs large tumor suppressor binds to protein 4.1. Lue RA, Marfatia SM, Branton D, Chishti AH. Proc Natl Acad Sci U S A 91 9818-9822 (1994)
  10. Structure of an intermediate state in protein folding and aggregation. Neudecker P, Robustelli P, Cavalli A, Walsh P, Lundström P, Zarrine-Afsar A, Sharpe S, Vendruscolo M, Kay LE. Science 336 362-366 (2012)
  11. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides. Musacchio A, Saraste M, Wilmanns M. Nat Struct Biol 1 546-551 (1994)
  12. Proline-rich sequences that bind to Src homology 3 domains with individual specificities. Alexandropoulos K, Cheng G, Baltimore D. Proc Natl Acad Sci U S A 92 3110-3114 (1995)
  13. Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Ventura S, Zurdo J, Narayanan S, Parreño M, Mangues R, Reif B, Chiti F, Giannoni E, Dobson CM, Aviles FX, Serrano L. Proc Natl Acad Sci U S A 101 7258-7263 (2004)
  14. Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Eck MJ, Atwell SK, Shoelson SE, Harrison SC. Nature 368 764-769 (1994)
  15. A Ras-GTPase-activating protein SH3-domain-binding protein. Parker F, Maurier F, Delumeau I, Duchesne M, Faucher D, Debussche L, Dugue A, Schweighoffer F, Tocque B. Mol Cell Biol 16 2561-2569 (1996)
  16. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Feng S, Kasahara C, Rickles RJ, Schreiber SL. Proc Natl Acad Sci U S A 92 12408-12415 (1995)
  17. The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Arcaro A, Guerreiro AS. Curr Genomics 8 271-306 (2007)
  18. Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain. Zurdo J, Guijarro JI, Jiménez JL, Saibil HR, Dobson CM. J Mol Biol 311 325-340 (2001)
  19. Direct characterization of amyloidogenic oligomers by single-molecule fluorescence. Orte A, Birkett NR, Clarke RW, Devlin GL, Dobson CM, Klenerman D. Proc Natl Acad Sci U S A 105 14424-14429 (2008)
  20. The appendage domain of alpha-adaptin is a high affinity binding site for dynamin. Wang LH, Südhof TC, Anderson RG. J Biol Chem 270 10079-10083 (1995)
  21. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions. Erpel T, Superti-Furga G, Courtneidge SA. EMBO J 14 963-975 (1995)
  22. The Drosophila tumor suppressor gene, dlg, is involved in structural plasticity at a glutamatergic synapse. Guan B, Hartmann B, Kho YH, Gorczyca M, Budnik V. Curr Biol 6 695-706 (1996)
  23. Ultrastructural organization of amyloid fibrils by atomic force microscopy. Chamberlain AK, MacPhee CE, Zurdo J, Morozova-Roche LA, Hill HA, Dobson CM, Davis JJ. Biophys J 79 3282-3293 (2000)
  24. Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation. Zhao ZS, Manser E, Lim L. Mol Cell Biol 20 3906-3917 (2000)
  25. DNM1, a dynamin-related gene, participates in endosomal trafficking in yeast. Gammie AE, Kurihara LJ, Vallee RB, Rose MD. J Cell Biol 130 553-566 (1995)
  26. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Irvin BJ, Williams BL, Nilson AE, Maynor HO, Abraham RT. Mol Cell Biol 20 9149-9161 (2000)
  27. Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain. Herskovits JS, Shpetner HS, Burgess CC, Vallee RB. Proc Natl Acad Sci U S A 90 11468-11472 (1993)
  28. A binding site for SH3 domains targets dynamin to coated pits. Shpetner HS, Herskovits JS, Vallee RB. J Biol Chem 271 13-16 (1996)
  29. Characterization of fus1 of Schizosaccharomyces pombe: a developmentally controlled function needed for conjugation. Petersen J, Weilguny D, Egel R, Nielsen O. Mol Cell Biol 15 3697-3707 (1995)
  30. Folding kinetics of the SH3 domain of PI3 kinase by real-time NMR combined with optical spectroscopy. Guijarro JI, Morton CJ, Plaxco KW, Campbell ID, Dobson CM. J Mol Biol 276 657-667 (1998)
  31. The SH3 domain of Eps8 exists as a novel intertwined dimer. Kishan KV, Scita G, Wong WT, Di Fiore PP, Newcomer ME. Nat Struct Biol 4 739-743 (1997)
  32. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition. Lim WA, Richards FM. Nat Struct Biol 1 221-225 (1994)
  33. NH2-terminal sequence of macrophage-expressed natural resistance-associated macrophage protein (Nramp) encodes a proline/serine-rich putative Src homology 3-binding domain. Barton CH, White JK, Roach TI, Blackwell JM. J Exp Med 179 1683-1687 (1994)
  34. Solution structure and peptide binding of the SH3 domain from human Fyn. Morton CJ, Pugh DJ, Brown EL, Kahmann JD, Renzoni DA, Campbell ID. Structure 4 705-714 (1996)
  35. Regulation of Class IA PI 3-kinases: C2 domain-iSH2 domain contacts inhibit p85/p110alpha and are disrupted in oncogenic p85 mutants. Wu H, Shekar SC, Flinn RJ, El-Sibai M, Jaiswal BS, Sen KI, Janakiraman V, Seshagiri S, Gerfen GJ, Girvin ME, Backer JM. Proc Natl Acad Sci U S A 106 20258-20263 (2009)
  36. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins. Knudsen BS, Zheng J, Feller SM, Mayer JP, Burrell SK, Cowburn D, Hanafusa H. EMBO J 14 2191-2198 (1995)
  37. Mutagenesis of human profilin locates its poly(L-proline)-binding site to a hydrophobic patch of aromatic amino acids. Björkegren C, Rozycki M, Schutt CE, Lindberg U, Karlsson R. FEBS Lett 333 123-126 (1993)
  38. Protein aggregation and amyloid fibril formation by an SH3 domain probed by limited proteolysis. Polverino de Laureto P, Taddei N, Frare E, Capanni C, Costantini S, Zurdo J, Chiti F, Dobson CM, Fontana A. J Mol Biol 334 129-141 (2003)
  39. Mechanism of constitutive phosphoinositide 3-kinase activation by oncogenic mutants of the p85 regulatory subunit. Shekar SC, Wu H, Fu Z, Yip SC, Nagajyothi, Cahill SM, Girvin ME, Backer JM. J Biol Chem 280 27850-27855 (2005)
  40. NMR structure of the N-terminal SH3 domain of GRB2 and its complex with a proline-rich peptide from Sos. Goudreau N, Cornille F, Duchesne M, Parker F, Tocqué B, Garbay C, Roques BP. Nat Struct Biol 1 898-907 (1994)
  41. Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline-rich motifs. Cussac D, Frech M, Chardin P. EMBO J 13 4011-4021 (1994)
  42. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5). O'Connell JC, McCallum JF, McPhee I, Wakefield J, Houslay ES, Wishart W, Bolger G, Frame M, Houslay MD. Biochem J 318 ( Pt 1) 255-261 (1996)
  43. Probing the mechanism of amyloidogenesis through a tandem repeat of the PI3-SH3 domain suggests a generic model for protein aggregation and fibril formation. Bader R, Bamford R, Zurdo J, Luisi BF, Dobson CM. J Mol Biol 356 189-208 (2006)
  44. Solution structure of pleckstrin homology domain of dynamin by heteronuclear NMR spectroscopy. Fushman D, Cahill S, Lemmon MA, Schlessinger J, Cowburn D. Proc Natl Acad Sci U S A 92 816-820 (1995)
  45. Structure of the N-terminal SH3 domain of GRB2 complexed with a peptide from the guanine nucleotide releasing factor Sos. Terasawa H, Kohda D, Hatanaka H, Tsuchiya S, Ogura K, Nagata K, Ishii S, Mandiyan V, Ullrich A, Schlessinger J. Nat Struct Biol 1 891-897 (1994)
  46. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions. Simon JA, Schreiber SL. Chem Biol 2 53-60 (1995)
  47. Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts. Wittekind M, Mapelli C, Lee V, Goldfarb V, Friedrichs MS, Meyers CA, Mueller L. J Mol Biol 267 933-952 (1997)
  48. Protein folding rates estimated from contact predictions. Punta M, Rost B. J Mol Biol 348 507-512 (2005)
  49. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA). Zhu Q, Zhang M, Rawlings DJ, Vihinen M, Hagemann T, Saffran DC, Kwan SP, Nilsson L, Smith CI, Witte ON, Chen SH, Ochs HD. J Exp Med 180 461-470 (1994)
  50. Solution structure and ligand-binding site of the carboxy-terminal SH3 domain of GRB2. Kohda D, Terasawa H, Ichikawa S, Ogura K, Hatanaka H, Mandiyan V, Ullrich A, Schlessinger J, Inagaki F. Structure 2 1029-1040 (1994)
  51. Ligand-induced EpoR internalization is mediated by JAK2 and p85 and is impaired by mutations responsible for primary familial and congenital polycythemia. Sulahian R, Cleaver O, Huang LJ. Blood 113 5287-5297 (2009)
  52. Partial unfolding of diverse SH3 domains on a wide timescale. Wales TE, Engen JR. J Mol Biol 357 1592-1604 (2006)
  53. Induction of early-response genes KC and JE by mycobacterial lipoarabinomannans: regulation of KC expression in murine macrophages by Lsh/Ity/Bcg (candidate Nramp). Roach TI, Chatterjee D, Blackwell JM. Infect Immun 62 1176-1184 (1994)
  54. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn. Panchamoorthy G, Fukazawa T, Stolz L, Payne G, Reedquist K, Shoelson S, Songyang Z, Cantley L, Walsh C, Band H. Mol Cell Biol 14 6372-6385 (1994)
  55. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. de Mendez I, Homayounpour N, Leto TL. Mol Cell Biol 17 2177-2185 (1997)
  56. High-resolution MAS NMR analysis of PI3-SH3 amyloid fibrils: backbone conformation and implications for protofilament assembly and structure . Bayro MJ, Maly T, Birkett NR, Macphee CE, Dobson CM, Griffin RG. Biochemistry 49 7474-7484 (2010)
  57. The crystal structure of human CskSH3: structural diversity near the RT-Src and n-Src loop. Borchert TV, Mathieu M, Zeelen JP, Courtneidge SA, Wierenga RK. FEBS Lett 341 79-85 (1994)
  58. Elucidation of the poly-L-proline binding site in Acanthamoeba profilin I by NMR spectroscopy. Archer SJ, Vinson VK, Pollard TD, Torchia DA. FEBS Lett 337 145-151 (1994)
  59. The tryptophan switch: changing ligand-binding specificity from type I to type II in SH3 domains. Fernandez-Ballester G, Blanes-Mira C, Serrano L. J Mol Biol 335 619-629 (2004)
  60. Identification and characterization of a novel SH3-domain binding protein, Sab, which preferentially associates with Bruton's tyrosine kinase (BtK). Matsushita M, Yamadori T, Kato S, Takemoto Y, Inazawa J, Baba Y, Hashimoto S, Sekine S, Arai S, Kunikata T, Kurimoto M, Kishimoto T, Tsukada S. Biochem Biophys Res Commun 245 337-343 (1998)
  61. Thermal unfolding of small proteins with SH3 domain folding pattern. Knapp S, Mattson PT, Christova P, Berndt KD, Karshikoff A, Vihinen M, Smith CI, Ladenstein R. Proteins 31 309-319 (1998)
  62. Solution structure of Escherichia coli FeoA and its potential role in bacterial ferrous iron transport. Lau CK, Ishida H, Liu Z, Vogel HJ. J Bacteriol 195 46-55 (2013)
  63. Stability and peptide binding affinity of an SH3 domain from the Caenorhabditis elegans signaling protein Sem-5. Lim WA, Fox RO, Richards FM. Protein Sci 3 1261-1266 (1994)
  64. Solution structure of GAP SH3 domain by 1H NMR and spatial arrangement of essential Ras signaling-involved sequence. Yang YS, Garbay C, Duchesne M, Cornille F, Jullian N, Fromage N, Tocque B, Roques BP. EMBO J 13 1270-1279 (1994)
  65. Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein. Carr MD, Bauer CJ, Gradwell MJ, Feeney J. Proc Natl Acad Sci U S A 91 2206-2210 (1994)
  66. Complete nucleotide sequence, expression, and chromosomal localisation of human mixed-lineage kinase 2. Dorow DS, Devereux L, Tu GF, Price G, Nicholl JK, Sutherland GR, Simpson RJ. Eur J Biochem 234 492-500 (1995)
  67. SH3 in muscles: solution structure of the SH3 domain from nebulin. Politou AS, Millevoi S, Gautel M, Kolmerer B, Pastore A. J Mol Biol 276 189-202 (1998)
  68. Ligand-induced changes in dynamics in the RT loop of the C-terminal SH3 domain of Sem-5 indicate cooperative conformational coupling. Ferreon JC, Hilser VJ. Protein Sci 12 982-996 (2003)
  69. Combinatorial Domain Hunting: An effective approach for the identification of soluble protein domains adaptable to high-throughput applications. Reich S, Puckey LH, Cheetham CL, Harris R, Ali AA, Bhattacharyya U, Maclagan K, Powell KA, Prodromou C, Pearl LH, Driscoll PC, Savva R. Protein Sci 15 2356-2365 (2006)
  70. Experimental mapping of soluble protein domains using a hierarchical approach. Pedelacq JD, Nguyen HB, Cabantous S, Mark BL, Listwan P, Bell C, Friedland N, Lockard M, Faille A, Mourey L, Terwilliger TC, Waldo GS. Nucleic Acids Res 39 e125 (2011)
  71. Selective insulin-induced activation of class I(A) phosphoinositide 3-kinase in PIKfyve immune complexes from 3T3-L1 adipocytes. Sbrissa D, Ikonomov O, Shisheva A. Mol Cell Endocrinol 181 35-46 (2001)
  72. Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences. Ren SY, Bolton E, Mohi MG, Morrione A, Neel BG, Skorski T. Mol Cell Biol 25 8001-8008 (2005)
  73. Stability and folding of the SH3 domain of Bruton's tyrosine kinase. Chen YJ, Lin SC, Tzeng SR, Patel HV, Lyu PC, Cheng JW. Proteins 26 465-471 (1996)
  74. Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population. Zaahl MG, Warnich L, Victor TC, Kotze MJ. Cancer Genet Cytogenet 159 48-52 (2005)
  75. Binding-induced folding under unfolding conditions: Switching between induced fit and conformational selection mechanisms. Sen S, Udgaonkar JB. J Biol Chem 294 16942-16952 (2019)
  76. PRR14 is a novel activator of the PI3K pathway promoting lung carcinogenesis. Yang M, Lewinska M, Fan X, Zhu J, Yuan ZM. Oncogene 35 5527-5538 (2016)
  77. Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activation. Liu X, Yang S, Hart JR, Xu Y, Zou X, Zhang H, Zhou Q, Xia T, Zhang Y, Yang D, Wang MW, Vogt PK. Proc Natl Acad Sci U S A 118 e2109327118 (2021)
  78. Determination of the solution structure of the SH3 domain of human p56 Lck tyrosine kinase. Hiroaki H, Klaus W, Senn H. J Biomol NMR 8 105-122 (1996)
  79. Two-dimensional electrophoretic analysis of mixed lineage kinase 2 N-terminal domain binding proteins. Rasmussen RK, Ji H, Eddes JS, Moritz RL, Reid GE, Simpson RJ, Dorow DS. Electrophoresis 19 809-817 (1998)
  80. Influence of the Bcg locus on macrophage response to the dimorphic fungus Candida albicans. Puliti M, Radzioch D, Mazzolla R, Barluzzi R, Bistoni F, Blasi E. Infect Immun 63 4170-4173 (1995)
  81. Comment Cell biology. Dynamin in synaptic dynamics. Vallee RB, Shpetner HS. Nature 365 107-108 (1993)
  82. Homology modeling of the Abl-SH3 domain. Pisabarro MT, Ortiz AR, Serrano L, Wade RC. Proteins 20 203-215 (1994)
  83. Revealing a concealed intermediate that forms after the rate-limiting step of refolding of the SH3 domain of PI3 kinase. Wani AH, Udgaonkar JB. J Mol Biol 387 348-362 (2009)
  84. SH3 domain of Bruton's tyrosine kinase can bind to proline-rich peptides of TH domain of the kinase and p120cbl. Patel HV, Tzeng SR, Liao CY, Chen SH, Cheng JW. Proteins 29 545-552 (1997)
  85. ORF-selector ESPRIT: a second generation library screen for soluble protein expression employing precise open reading frame selection. An Y, Yumerefendi H, Mas PJ, Chesneau A, Hart DJ. J Struct Biol 175 189-197 (2011)
  86. Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα. Hart JR, Liu X, Pan C, Liang A, Ueno L, Xu Y, Quezada A, Zou X, Yang S, Zhou Q, Schoonooghe S, Hassanzadeh-Ghassabeh G, Xia T, Shui W, Yang D, Vogt PK, Wang MW. Proc Natl Acad Sci U S A 119 e2210769119 (2022)
  87. News Signalling an interest. Yu H, Schreiber SL. Nat Struct Biol 1 417-420 (1994)
  88. pH-Dependent self-association of the Src homology 2 (SH2) domain of the Src homologous and collagen-like (SHC) protein. Réty S, Fütterer K, Grucza RA, Munoz CM, Frazier WA, Waksman G. Protein Sci 5 405-413 (1996)
  89. Interactions of phosphatidylinositol 3-kinase Src homology 3 domain with its ligand peptide studied by absorption, circular dichroism, and UV resonance raman spectroscopies. Okishio N, Nagai M, Fukuda R, Nagatomo S, Kitagawa T. Biopolymers 57 208-217 (2000)
  90. Identifying protein domains by global analysis of soluble fragment data. Bulloch EM, Kingston RL. Anal Biochem 465 53-62 (2014)
  91. ProteinCT: An implementation of the protein circuit topology framework. Moes D, Banijamali E, Sheikhhassani V, Scalvini B, Woodard J, Mashaghi A. MethodsX 9 101861 (2022)
  92. NMR assignments of PI3-SH3 domain aided by protonless NMR spectroscopy. Hsu ST. Biomol NMR Assign 8 291-295 (2014)


Quick links